Salvia BioElectronics
Salvia is a startup focused on delivering bioelectronic solutions for chronic migraine sufferers.
Salvia is a startup focused on delivering bioelectronic solutions for chronic migraine sufferers.
Salvia BioElectronics is a Dutch startup dedicated to providing bioelectronic solutions to individuals suffering from chronic migraines. The company derives its name from the Latin word salvere, which translates to the preservation of good health. Drawing inspiration from the historical use of the Salvia plant to alleviate mental disorders, pain, and headaches, Salvia BioElectronics aims to harness bioelectronics to restore wellness for those affected by persistent migraines.
Since its establishment in 2017, Salvia BioElectronics has been operating in the fields of Biotechnology, Health and Wellness, and Medical Devices. The company's commitment to innovation in the burgeoning sector of bioelectronics has garnered significant attention.
The most recent milestone for Salvia BioElectronics was its €53.00M Series B investment on 27 May 2025. This substantial investment was facilitated by a consortium of prominent backers including Invest-NL, Panakes Partners, SHS Capital, Thuja Capital, Inkef, Innovation Industries, EIC Fund, Dolby Family Ventures, and BOM.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | €53.00M | 9 |
|
27 May 2025 |
| Non Equity Assistance | Unknown | 1 |
|
29 May 2024 |
| Grant | Unknown | 1 | EIC Accelerator | 28 Feb 2024 |
| Series A | $31.00M | 6 |
|
22 Sep 2020 |
| Seed Round | €1.80M | 2 |
|
31 Jan 2019 |
We care about your data, and we'd love to use cookies make your experience better.
